Navigation Links
Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
Date:2/12/2008

DAYTONA BEACH, Fla., Feb. 12 /PRNewswire/ -- CORD:USE Cord Blood Bank is proud to announce that two-time defending NASCAR Sprint Cup Series Champion Jimmie Johnson has joined its team. "We're honored to have this NASCAR superstar and terrific person on our team," states Dr. Edward Guindi, President and CEO of CORD:USE. Jimmie Johnson joins CORD:USE as a spokesperson to participate in its "Help Win the Race for Life(TM)" campaign.

"I'm excited about telling people the benefits of umbilical cord blood donation and cord blood stem cell treatments for people in life-or-death situations," says Johnson.

"The fact that umbilical cord blood, which is normally just thrown out after a baby's born, could be donated and used to save someone's life - that just blows me away. We've got over 75 million good-hearted NASCAR fans out there, and together we can make a real difference in CORD:USE's efforts to save lives. I support this with my whole heart, and you better believe when I'm a parent some day, it's something that I'm going to participate in first hand."

Jimmie Johnson joins other NASCAR greats Rusty Wallace and Michael Waltrip, who have played an active role in increasing public awareness of cord blood donation and the dozens of current applications utilizing cord blood stem cells in transplantation.

"They call it The Race for Life, and it's a race team I'm excited to be a part of. CORD:USE's team is made up of many of the top physicians and scientists in this important medical field, which is saving thousands of lives. You know me, every race I'm in, I want to win - and I'm especially determined to win this one," says Johnson.

Cord blood stem cells have already been used to treat more than 10,000 patients, saving thousands of people who would otherwise not have had a chance of survival. There are currently more than 70 different diseases that have been successfully treated utilizing cord blood stem cells.

About CORD:USE Cord Blood Bank

The CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, has assembled a world-class team of scientists and physicians who are pioneers and world leaders in the fields of cord blood stem cell banking and transplantation. CORD:USE is creating a large, ethnically diverse, high- quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE Cord Blood Bank has entered into agreements with hospitals across the country to provide parents the opportunity to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters, throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit our website http://www.corduse.com .


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
2. Hyperion Therapeutics Secures $40 Million In Series B Round
3. Enobia Pharma Raises $40.1 Million Series B Financing
4. OpGen Announces $23.6 Million Series A Financing
5. Amyris Biotechnologies Announces $70 Million Series B Round
6. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
7. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
8. VisEn Medical Raises $7 Million in Series B Financing
9. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
10. BioVex Closes Second Round of Series E Financing
11. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market has ... The market is expected to grow at a five-year compound annual ... $50.6 billion in 2015 to $96.6 billion in 2020. ... to 2020) are discussed. As well, new products approved in 2013 ...
Breaking Biology Technology:
(Date:6/22/2016)... June 22, 2016   Acuant , ... verification solutions, has partnered with RightCrowd ® ... for Visitor Management, Self-Service Kiosks and Continuous ... that add functional enhancements to existing physical ... and venues with an automated ID verification ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):